Showing results (111-120 of 39,531) with videos related to

Sort By:
Pageof 3,954
Chemical Reviews|October 18, 2021
Toolbox for Distal C-H Bond Functionalizations in Organic MoleculesSoumya Kumar Sinha, Srimanta Guin, Sudip Maiti, et al.
ACS Omega|November 15, 2021
Catalytic Use toward the Redox Reaction of Toxic Industrial Wastes in Innocuous Aqueous Medium and Antibacterial Activity of Novel Cu Ag Zn1-2 O NanocompositesAnik Sinha, Sanjay Kumar Sahu, Suman Biswas, et al.
Environmental Science and Pollution Research International|May 29, 2017
Human health risk exposure with respect to particulate-bound polycyclic aromatic hydrocarbons at mine fire-affected coal mining complexDebananda Roy, Yong-Chil Seo, Sweta Sinha, et al.
Journal of Laboratory Physicians|October 21, 2014
Cytodiagnosis of Extra-nasal Rhinosporidiosis: A Study of 16 Cases from Endemic AreaSubrata Pal, Srabani Chakrabarti, Biplab Kr Biswas, et al.
The Journal of Chemical Physics|April 22, 2006
Origin of threefold symmetric torsional potential of methyl group in 4-methylstyreneRajeev K Sinha, B Pradhan, Bhanu P Singh, et al.
Materials (Basel, Switzerland)|February 25, 2023
Feasibility Study of Reclaimed Asphalt Pavements (RAP) as Recycled Aggregates Used in Rigid Pavement ConstructionM K Diptikanta Rout, Surya Kant Sahdeo, Sabyasachi Biswas, et al.
International Journal of Biological Macromolecules|November 22, 2019
Removal of an atypical region from a staphylococcal cyclophilin affects its structure, function, stability, and shapeSoham Seal, Nilkanta Chowdhury, Ria Biswas, et al.
Scientific Reports|June 9, 2026
Lineage-specific selection signals in the Growth arrest-specific protein 8 (GAS8) domain protein of Trypanosoma melophagiumAnumita Das, Arnab Ghosh, Swarnamoy Pal, et al.
Asian Journal of Transfusion Science|June 25, 2026
Transfusion management in two patients with anti-f antibodies - A case report and review of the literatureDebapriya Basu, Durba Biswas, Ayesha Sinha, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study)Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
Pageof 3,954